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IMPT plans were prescribed to deliver 67.5 Gy to the prostate 
and 60 Gy to the seminal vesicles over 25 fractions. In the 
case of IMPT, corresponding doses were prescribed as 
Gy(RBE). The dosimetric and volumetric distributions for each 
treatment plan were evaluated with respect to risk of 
radiation-induced cancer by using both the linear-no-
threshold (LNT) model and the non-linear competitive risk 
model which incorporates cell killing vs induction of 
carcinogenic mutations in fractionated RT [Dasu et al, 2005]. 
The organ equivalent dose (OED) concept [Schneider et al, 
2005] was adapted to both risk-response models and served 
as a relative risk measure, while estimates of absolute risks 
were based on five nominal risk calculation methods of 
organ-specific radiation induced cancer as suggested by the 
International Commission on Radiological Protection [ICRP 
103, 2007]. 
Results: All treatment plans fulfilled the plan optimisation 
criteria as defined by standardised treatment protocols. The 
IMPT generally achieved a lower integrated dose to healthy 
tissues (Figure 1), and mean doses to the bladder and rectum 
were reduced as well as the percentage of the volumes 
receiving 20 Gy and 40 Gy. The linear risk models compared 
in favour of IMPT for both organs at risk (Table 1). The 
corresponding results using the competition model resulted in 
a 1.7 times higher risk of bladder cancer from VMAT 
compared to IMPT, while no significant difference was seen 
between the two techniques for the rectum. Translating the 
relative scoring from the competition model into absolute 
quantities, the risks for VMAT and IMPT were 0.2-0.5 % and 
0.1-0.3 %, respectively. The risks of radiation induced rectal 
cancer were estimated to 0.1-0.3 % for both radiation 
modalities. 
 
 
 
Conclusions: When incorporating effects of non-linear dose-
response and fractionated RT, VMAT resulted in 1.7 times 
higher risk of radiation-induced bladder cancer compared to 
IMPT, while no significant difference between the two 
techniques was found for secondary rectal cancer. 
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Purpose/Objective: Hodgkin's lymphoma (HL) radiation 
treatments may be responsible for late-phase subclinical lung 
radiation-induced injury such as fibrosis with radiological 
lung density changes detectable by computed tomography 
(CT). Using a machine-learning technique, our purpose was to 
investigate variable importance in predicting radiation-
induced CT changes in HL survivors treated with 
chemotherapy and radiotherapy (RT). The potential role of 
heart irradiation on the risk of CT changes was also 
investigated. 
Materials and Methods: One hundred ten consecutive 
patients treated with sequential chemo-radiotherapy for 
supradiaphragmatic HL (median follow-up 68 months, range 
13-140) were retrospectively reviewed for radiological signs 
of lung CT changes. All patients were treated with three-
dimensional conformal radiotherapy with a median total dose 
of 30.6 Gy (range 14.4-45). At a median time of 16.5 months 
(range 6-102), 18 of 110 patients (16.4%) developed lung 
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radiological changes on CT after treatment. Median patient 
age was 28 years (range 6–71). In addition to lung irradiation 
factors, clinical variables, along with left and right lung and 
heart dose-volume histogram parameters, were included in 
the analysis. We applied a random forest (RF) algorithm to 
assess the prediction power and to measure the importance 
of the variables.  We split the cohort into two groups with 
one group (toxicity group) having lung toxicity and the other 
group (case group) without toxicity. To make balanced data, 
we randomly selected 18 samples from the case group and 
combined them with 18 samples in the toxicity group, 
resulting in 36 patients in total. With the 36 patients, we 
performed a two-stage of RF. In the first RF, all predictors 
were used, selecting 1/3 of predictors at node split. Based on 
the out-of-bag (OOB) samples, we calculated the importance 
of each variable and removed 1/3 insignificant variables for 
further analysis. Then, using the remaining predictors, the 
second RF was performed, still choosing 1/3 of predictors at 
each node split from the remaining predictors. This 
procedure was iterated 50 times. Model performance was 
assessed using the area under the receiver operating 
characteristic curve (AUC). 
Results: In the first RF, AUC=0.62 was obtained on average. 
In the second RF, a slightly better performance was obtained 
with AUC=0.64 on average. RF variable importance scores for 
the top 20 predictors relevant to CT changes obtained in the 
first RF are presented in figure 1. It was observed that both 
lung and heart-related predictors were highly ranked, 
suggesting that there is a correlation between doses received 
in heart and CT changes in lung. 
Figure 1 
 
 
Conclusions: Applying RF method, we showed the importance 
of jointly considering lung and heart irradiation in the 
prediction of subclinical radiation-induced lung fibrosis. 
Although asymptomatic, lung fibrosis could result in future 
respiratory insufficiency and its prediction is important for 
long-term quality of life for HL survivors.  
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Purpose/Objective: To investigate whether computer-
optimized fully automated VMAT planning may improve 
treatment plans for patients with liver metastases. 
Materials and Methods: Nine patients with liver metastases, 
previously treated in our clinic at a Cyberknife (CK) to 60 Gy 
prescribed at the 80% isodose, were included in this study. 
For each study patient, using our in-house developed multi-
criterial optimizer for fully automated plan generation, an 
optimized plan with 29 equidistant coplanar beams was 
generated. Our optimizer uses the 2-phase ε-constraint 
(2pεc) lexicographic optimization algorithm, based on a fixed 
list of hard constraints and prioritized objectives. This so-
called 'wish-list' is generated in an iterative procedure based 
on physicians' evaluation of initial plans generated for the 
first few patients. First priority was to achieve the highest 
possible coverage of the planning target volume (PTV) by the 
prescription dose, while not violating the clinically applied 
hard constraints. After optimization, a template containing 
the achieved results for the objectives and constraints is 
automatically generated, and fed into the clinical TPS 
(Monaco 5.0) to generate a clinically deliverable dual-arc 
VMAT plan without requiring any human interference. This 
plan was compared to the manually generated CK plan, 
comprising multiple non-coplanar beams, with respect to PTV 
dose coverage, mean dose and near-maximum dose (D2%) in 
the OARs. 
Results: In the automatically generated VMAT plans, PTV 
coverage increased by 0.8% on average (p = 0.594). All VMAT 
plans complied with the clinical constraints. This also applied 
to the patients in which the maximum dose in the spinal cord 
was slightly, but not significantly higher than in the CK plans 
(p = 0.314). For most of the other OARs large reductions in 
mean and near-maximum doses were observed (see Figure). 
The volumes of healthy liver receiving 15 Gy, 18 Gy and 21.6 
Gy (clinical constraints) were reduced by 1%, 3.7% and 1.6%, 
respectively. In addition the mean dose in the healthy liver 
was significantly reduced by 2.5±0.8 Gy (p = 0.008). The 
near-maximum dose in the bowel, duodenum, esophagus, 
heart, right kidney and gallbladder was significantly lower (p 
< 0.05), with population mean reductions of 20.7%, 22.5%, 
11.9%, 27.4%, 18.8% and 20.6%, respectively. Estimated 
delivery times for VMAT were a factor of eight shorter 
compared to CK plans (5.3±1.3 minutes versus 42±12 
minutes). 
 
 
Figure: Difference in OARs near-maximum and mean doses for 
automatically generated VMAT plans compared to CK plans. 
The dots give the population mean values for the 9 study 
patients and the error bars indicate ± 1 standard deviation. 
